Measurment of GFR by Nasal Sensors

This study has been completed.
Sponsor:
Information provided by:
Rambam Health Care Campus
ClinicalTrials.gov Identifier:
NCT01274169
First received: January 10, 2011
Last updated: NA
Last verified: February 2008
History: No changes posted
  Purpose

to measure kidney function by measuring blood creatinine and to compare it to the measurment of GFR by Nanotechnology


Condition
Measure GFR by Nasal Sensor

Study Type: Observational

Further study details as provided by Rambam Health Care Campus:

Study Start Date: March 2008
Estimated Study Completion Date: March 2010
  Eligibility

Ages Eligible for Study:   18 Years to 70 Years
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   Yes
Sampling Method:   Non-Probability Sample
Study Population

volunteers subjects with different stages of CKD

Criteria

Inclusion Criteria:

adults between 18-70 yrs

Exclusion Criteria:

subject under 18

  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

No Contacts or Locations Provided
  More Information

No publications provided

Responsible Party: Ministry of health israel
ClinicalTrials.gov Identifier: NCT01274169     History of Changes
Other Study ID Numbers: NANOCTIL
Study First Received: January 10, 2011
Last Updated: January 10, 2011
Health Authority: United States: Food and Drug Administration

ClinicalTrials.gov processed this record on October 01, 2014